{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,21]],"date-time":"2026-11-21T00:10:21Z","timestamp":1795219821194,"version":"4.10.3"},"reference-count":33,"publisher":"Elsevier BV","issue":"10154","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/s0140-6736(18)32001-4","type":"journal-article","created":{"date-parts":[[2018,9,22]],"date-time":"2018-09-22T13:49:14Z","timestamp":1537624154000},"page":"1235-1245","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":138,"title":["Thin composite wire strut, durable polymer-coated (Resolute Onyx) versus ultrathin cobalt\u2013chromium strut, bioresorbable polymer-coated (Orsiro) drug-eluting stents in allcomers with coronary artery disease (BIONYX): an international, single-blind, randomised non-inferiority trial"],"prefix":"10.1016","volume":"392","author":[{"given":"Clemens","family":"von Birgelen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Zocca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosaly A","family":"Buiten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gillian A J","family":"Jessurun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl E","family":"Schotborgh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariel","family":"Roguin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter W","family":"Danse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edouard","family":"Benit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adel","family":"Aminian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K Gert","family":"van Houwelingen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rutger L","family":"Anthonio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin G","family":"Stoel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samer","family":"Somi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Hartmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerard C M","family":"Linssen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carine J M","family":"Doggen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marlies M","family":"Kok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S0140-6736(18)32001-4_bib1","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1161\/CIRCULATIONAHA.106.666800","article-title":"Stent thrombosis late after implantation of first-generation drug-eluting stents: a cause for concern","volume":"115","author":"Camenzind","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/S0140-6736(18)32001-4_bib2","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jacc.2006.03.042","article-title":"Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk","volume":"48","author":"Joner","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/S0140-6736(18)32001-4_bib3","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/S0140-6736(08)61244-1","article-title":"Biolimus-eluting stent with biodegradable polymer versus sirolimus-eluting stent with durable polymer for coronary revascularisation (LEADERS): a randomised non-inferiority trial","volume":"372","author":"Windecker","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/S0140-6736(18)32001-4_bib4","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1056\/NEJMoa0910496","article-title":"Everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease","volume":"362","author":"Stone","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/S0140-6736(18)32001-4_bib5","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0140-6736(09)62127-9","article-title":"Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice (COMPARE): a randomised trial","volume":"375","author":"Kedhi","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/S0140-6736(18)32001-4_bib6","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S0140-6736(17)31927-X","article-title":"Coronary balloon angioplasty, stents and scaffolds","volume":"390","author":"Byrne","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/S0140-6736(18)32001-4_bib7","doi-asserted-by":"crossref","first-page":"f6530","DOI":"10.1136\/bmj.f6530","article-title":"Safety and efficacy outcomes of first and second generation durable polymer drug-eluting stents and biodegradable polymer biolimus eluting stents in clinical practice: comprehensive network meta-analysis","volume":"347","author":"Navarese","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/S0140-6736(18)32001-4_bib8","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1056\/NEJMoa1004130","article-title":"Comparison of zotarolimus-eluting and everolimus-eluting coronary stents","volume":"363","author":"Serruys","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/S0140-6736(18)32001-4_bib9","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1016\/j.jacc.2012.01.008","article-title":"A randomized controlled trial in second-generation zotarolimus-eluting Resolute stents versus everolimus-eluting Xience V stents in real-world patients: the TWENTE trial","volume":"59","author":"von Birgelen","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/S0140-6736(18)32001-4_bib10","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0140-6736(13)62037-1","article-title":"Third-generation zotarolimus-eluting and everolimus-eluting stent in all-comer patients requiring a percutaneous coronary intervention (DUTCH PEERS): a randomised, single-blind, multicentre, non-inferiority trial","volume":"383","author":"von Birgelen","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/S0140-6736(18)32001-4_bib11","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/S0140-6736(14)61794-3","article-title":"Zotarolimus-eluting durable-polymer-coated stents versus a biolimus-eluting biodegradable-polymer-coated stent in unselected patients undergoing percutaneous coronary intervention (SORT OUT VI): a randomised non-inferiority trial","volume":"385","author":"Raungaard","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/S0140-6736(18)32001-4_bib12","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1016\/S0140-6736(16)31920-1","article-title":"Very thin strut biodegradable polymer everolimus-eluting and sirolimus-eluting stents versus durable polymer zotarolimus-eluting stents in allcomers with coronary artery disease (BIO-RESORT): a three-arm, randomised, non-inferiority trial","volume":"388","author":"von Birgelen","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/S0140-6736(18)32001-4_bib13","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1161\/CIRCULATIONAHA.117.028885","article-title":"Randomized comparison of ridaforolimus and zotarolomis-eluting coronary stents in patients with coronary artery disease: primary results from the BIONICS trial (BioNIR) ridaforolimus-eluting coronary stent system in coronary stenosis)","volume":"136","author":"Kandzari","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/S0140-6736(18)32001-4_bib14","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1161\/CIRCULATIONAHA.110.003210","article-title":"Stent thrombogenicity early in high-risk interventional settings is driven by stent design and deployment and protected by polymer-drug coatings","volume":"123","author":"Kolandaivelu","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/S0140-6736(18)32001-4_bib15","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCULATIONAHA.118.034456","article-title":"Newer generation ultra-thin strut drug-eluting stents versus older second-generation thicker strut drug-eluting stents for coronary artery disease: a meta-analysis of randomized trials","author":"Bangalore","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/S0140-6736(18)32001-4_bib16","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.ijcard.2012.09.170","article-title":"Importance of knowing stent design threshold diameters and post-dilatation capacities to optimise stent selection and prevent stent overexpansion\/incomplete apposition during PCI","volume":"166","author":"Foin","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/S0140-6736(18)32001-4_bib17","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.ijcard.2016.06.097","article-title":"Over-expansion capacity and stent design model: an update with contemporary DES platforms","volume":"221","author":"Ng","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1016\/S0140-6736(18)32001-4_bib18","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.jacc.2004.12.066","article-title":"Stent underexpansion and residual reference segment stenosis are related to stent thrombosis after sirolimus-eluting stent implantation: an intravascular ultrasound study","volume":"45","author":"Fujii","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/S0140-6736(18)32001-4_bib19","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1161\/CIRCULATIONAHA.106.658237","article-title":"Incomplete stent apposition and very late stent thrombosis after drug-eluting stent implantation","volume":"115","author":"Cook","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/S0140-6736(18)32001-4_bib20","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1016\/S0140-6736(14)61038-2","article-title":"Ultrathin strut biodegradable polymer sirolimus-eluting stent versus durable polymer everolimus-eluting stent for percutaneous coronary revascularisation (BIOSCIENCE): a randomised, single-blind, non-inferiority trial","volume":"384","author":"Pilgrim","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/S0140-6736(18)32001-4_bib21","doi-asserted-by":"crossref","first-page":"e003610","DOI":"10.1161\/CIRCINTERVENTIONS.115.003610","article-title":"Randomized comparison of a biodegradable polymer ultrathin strut sirolimus-eluting stent with a biodegradable polymer biolimus-eluting stent in patients treated with percutaneous coronary intervention","volume":"9","author":"Jensen","year":"2016","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/S0140-6736(18)32001-4_bib22","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1016\/S0140-6736(17)32249-3","article-title":"Ultrathin, bioresorbable polymer sirolimus-eluting stents versus thin, durable polymer everolimus-eluting stents in patients undergoing coronary revascularisation (BIOFLOW V): a randomised trial","volume":"390","author":"Kandzari","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/S0140-6736(18)32001-4_bib23","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ahj.2017.12.011","article-title":"Bioresorbable polymer-coated Orsiro versus durable polymer-coated Resolute Onyx stents (BIONYX): rationale and design of the randomized TWENTE IV multicenter trial","volume":"198","author":"van der Heijden","year":"2018","journal-title":"Am Heart J"},{"key":"10.1016\/S0140-6736(18)32001-4_bib24","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1161\/CIRCULATIONAHA.106.685313","article-title":"Clinical end points in coronary stent trials: a case for standardized definitions","volume":"115","author":"Cutlip","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/S0140-6736(18)32001-4_bib25","doi-asserted-by":"crossref","first-page":"871","DOI":"10.4244\/EIJV5I7A146","article-title":"Myocardial infarction adjudication in contemporary all-comer stent trials: balancing sensitivity and specificity. Addendum to the historical MI definitions used in stent studies","volume":"5","author":"Vranckx","year":"2010","journal-title":"EuroIntervention"},{"key":"10.1016\/S0140-6736(18)32001-4_bib26","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1093\/eurheartj\/ehu026","article-title":"Lack of association between dual antiplatelet therapy use and stent thrombosis between 1 and 12 months following resolute zotarolimus-eluting stent implantation","volume":"35","author":"Silber","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/S0140-6736(18)32001-4_bib27","doi-asserted-by":"crossref","first-page":"e004762","DOI":"10.1161\/CIRCINTERVENTIONS.116.004762","article-title":"Comparison of acute thrombogenicity for metallic and polymeric bioabsorbable scaffolds: Magmaris versus Absorb in a porcine arteriovenous shunt model","volume":"10","author":"Waksman","year":"2017","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/S0140-6736(18)32001-4_bib28","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.jcin.2014.05.016","article-title":"Stent thrombosis a clinical perspective","volume":"10","author":"Claessen","year":"2014","journal-title":"J Am Coll Cardiol Intv"},{"key":"10.1016\/S0140-6736(18)32001-4_bib29","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1016\/j.jcin.2017.05.004","article-title":"First report of the Resolute Onyx 2\u00b70 mm zotarolimus-eluting stent for the treatment of coronary lesions with very small reference vessel diameter","volume":"10","author":"Price","year":"2017","journal-title":"J Am Coll Cardiol Intv"},{"key":"10.1016\/S0140-6736(18)32001-4_bib30","article-title":"Comparison of short-term clinical outcomes between Resolute Onyx zotarolimus-eluting stents and everolimus-eluting stent in patients with acute myocardial infarction: results from the Korea Acute Myocardial infarction Registry (KAMIR)","author":"Kim","year":"2018","journal-title":"Cardiol J"},{"key":"10.1016\/S0140-6736(18)32001-4_bib31","article-title":"Safety and efficacy of the next generation Resolute Onyx zotarolimus-eluting stent: primary outcome of the RESOLUTE ONYX core trial","author":"Price","year":"2017","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/S0140-6736(18)32001-4_bib32","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S0140-6736(12)61852-2","article-title":"Abluminal biodegradable polymer biolimus-eluting stent versus durable polymer everolimus-eluting stent (COMPARE II): a randomised, controlled, non-inferiority trial","volume":"381","author":"Smits","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/S0140-6736(18)32001-4_bib33","doi-asserted-by":"crossref","first-page":"e002372","DOI":"10.1161\/CIRCINTERVENTIONS.114.002372","article-title":"Efficacy and safety of a novel bioabsorbable polymer-coated, everolimus-eluting coronary stent","volume":"8","author":"Kereiakes","year":"2015","journal-title":"Circ Cardiovasc Interv"}],"container-title":["The Lancet"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0140673618320014?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0140673618320014?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:12:00Z","timestamp":1758845520000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0140673618320014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":33,"journal-issue":{"issue":"10154","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["S0140673618320014"],"URL":"https:\/\/doi.org\/10.1016\/s0140-6736(18)32001-4","relation":{},"ISSN":["0140-6736"],"issn-type":[{"value":"0140-6736","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Thin composite wire strut, durable polymer-coated (Resolute Onyx) versus ultrathin cobalt\u2013chromium strut, bioresorbable polymer-coated (Orsiro) drug-eluting stents in allcomers with coronary artery disease (BIONYX): an international, single-blind, randomised non-inferiority trial","name":"articletitle","label":"Article Title"},{"value":"The Lancet","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S0140-6736(18)32001-4","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S0140-6736(18)32334-1","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}